1 most recent filing and news item mentioning NVTA. Updated every 60 seconds.
OfferingJun 30, 2026Neutral
Nuvation Bio agreed to sell $250 million of 0.75% convertible senior notes due 2032. This financing agreement was negotiated with Jefferies, Citigroup, and Cantor Fitzgerald as underwriters.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.